CJ-13217

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCJ-13217
Drug Alias NameCJ-13136CJ-13566CJ-13217CJ-13536CJ-13565 +[8] 
ClassificationSmall molecules
Mechanisms of ActionBacterial DNA gyrase inhibitors
TargetsBacterial DNA gyrase
Therapy Area/IndicationsHelicobacter pylori infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infection

Other Information

ATC CodeN/A
Related LinksN/A